Status:
COMPLETED
Human Papillomavirus Education Programs
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Conditions:
Human Papillomavirus-Related Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial aims to implement a culturally-tailored educational outreach actives with the goal of increasing knowledge of human papillomavirus (HPV) types that can lead to cancer and uptake of...
Detailed Description
PRIMARY OBJECTIVE: I. To implement culturally tailored educational outreach activities with the goal of increasing knowledge of HPV types that can lead to cancer and uptake of the available vaccine. ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- 18 years of age and older
- From Ohio
Exclusion
Key Trial Info
Start Date :
April 27 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04880837
Start Date
April 27 2022
End Date
December 31 2022
Last Update
November 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States, 43210